Your browser doesn't support javascript.
loading
Omalizumab facilitates rapid oral desensitization for peanut allergy.
MacGinnitie, Andrew J; Rachid, Rima; Gragg, Hana; Little, Sara V; Lakin, Paul; Cianferoni, Antonella; Heimall, Jennifer; Makhija, Melanie; Robison, Rachel; Chinthrajah, R Sharon; Lee, John; Lebovidge, Jennifer; Dominguez, Tina; Rooney, Courtney; Lewis, Megan Ott; Koss, Jennifer; Burke-Roberts, Elizabeth; Chin, Kimberly; Logvinenko, Tanya; Pongracic, Jacqueline A; Umetsu, Dale T; Spergel, Jonathan; Nadeau, Kari C; Schneider, Lynda C.
Afiliação
  • MacGinnitie AJ; Division of Immunology, Boston Children's Hospital, Boston, Mass.
  • Rachid R; Division of Immunology, Boston Children's Hospital, Boston, Mass.
  • Gragg H; Clinical Research Center, Boston Children's Hospital, Boston, Mass.
  • Little SV; Division of Immunology, Boston Children's Hospital, Boston, Mass.
  • Lakin P; Clinical Research Center, Boston Children's Hospital, Boston, Mass.
  • Cianferoni A; Division of Allergy, Children's Hospital of Philadelphia, Philadelphia, Pa.
  • Heimall J; Division of Allergy, Children's Hospital of Philadelphia, Philadelphia, Pa.
  • Makhija M; Allergy Division, the Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Ill.
  • Robison R; Allergy Division, the Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Ill.
  • Chinthrajah RS; Division of Allergy, Immunology, and Rheumatology, Lucille Packard Children's Hospital, Palo Alto, Calif.
  • Lee J; Division of Immunology, Boston Children's Hospital, Boston, Mass.
  • Lebovidge J; Division of Immunology, Boston Children's Hospital, Boston, Mass.
  • Dominguez T; Division of Allergy, Immunology, and Rheumatology, Lucille Packard Children's Hospital, Palo Alto, Calif.
  • Rooney C; Division of Allergy, Children's Hospital of Philadelphia, Philadelphia, Pa.
  • Lewis MO; Division of Allergy, Children's Hospital of Philadelphia, Philadelphia, Pa.
  • Koss J; Allergy Division, the Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Ill.
  • Burke-Roberts E; Division of Immunology, Boston Children's Hospital, Boston, Mass.
  • Chin K; Clinical Research Center, Boston Children's Hospital, Boston, Mass.
  • Logvinenko T; Clinical Research Center, Boston Children's Hospital, Boston, Mass.
  • Pongracic JA; Allergy Division, the Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Ill.
  • Umetsu DT; Genentech, South San Francisco, Calif.
  • Spergel J; Division of Allergy, Children's Hospital of Philadelphia, Philadelphia, Pa.
  • Nadeau KC; Division of Allergy, Immunology, and Rheumatology, Lucille Packard Children's Hospital, Palo Alto, Calif.
  • Schneider LC; Division of Immunology, Boston Children's Hospital, Boston, Mass. Electronic address: Lynda.Schneider@childrens.harvard.edu.
J Allergy Clin Immunol ; 139(3): 873-881.e8, 2017 Mar.
Article em En | MEDLINE | ID: mdl-27609658
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dessensibilização Imunológica / Antialérgicos / Hipersensibilidade a Amendoim / Omalizumab Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dessensibilização Imunológica / Antialérgicos / Hipersensibilidade a Amendoim / Omalizumab Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article